JUNNESH MOUSHI: Open Payments
NPI 1083395966 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$579 in 29 payments from 14 companies in 2025. Trend: 2023 $308 · 2024 $624 · 2025 $579
Food & beverage: $579
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $135 |
| ABBVIE INC. | 4 | $81 |
| PFIZER INC. | 4 | $79 |
| Boston Scientific Corporation | 1 | $49 |
| Lilly USA, LLC | 3 | $42 |
| GlaxoSmithKline, LLC. | 2 | $33 |
| Inspire Medical Systems, Inc. | 1 | $31 |
| Edwards Lifesciences Corporation | 1 | $24 |
| Abbott Laboratories | 1 | $21 |
| Exact Sciences Corporation | 1 | $20 |
Products named: Ozempic, PREVNAR 20, General - Therapies, QULIPTA, VRAYLAR, INSPIRE, MOUNJARO, SAPIEN 3 Ultra RESILIA.
Industry payments across AZ — which companies pay providers there.
